Dublin, Aug. 24, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Prophylactic Human Vaccines - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Prophylactic Human Vaccines in US$ Million by the following Product Segments: Pediatric Prophylactic Vaccines, and Adult Prophylactic Vaccines.
The report profiles 63 companies including many key and niche players such as
- ALK
- Abelló A/S (Denmark)
- Altimmune, Inc. (US)
- Bavarian Nordic A/S (Denmark)
- BiondVax Pharmaceuticals Ltd. (Israel)
- Bharat Biotech International Limited (India)
- GlaxoSmithKline Plc. (UK)
- Hualan Biological Engineering Inc. (China)
- Janssen Pharmaceuticals, Inc. (US)
- MedImmune (US)
- Merck & Co., Inc. (US)
- Pfizer Inc. (US)
- Sanofi Pasteur SA (France)
- Serum Institute of India Pvt. Ltd. (India)
- Shanghai BravoBio Co., Ltd. (China)
- Seqirus (UK)
- SK Chemicals Co., Ltd. (Korea)
- Takeda Pharmaceutical Company Limited (Japan)
- Zydus Cadila (India)
Key Topics Covered:
1. Market Overview & Outlook
2. Market Trends & Issues
3. Competitive Landscape
4. Product Overview
5. Clinical Trials In The Vaccines Market
6. Product Launches/Approvals
7. Recent Industry Activity
8. Focus On Select Players
9. Global Market Perspective
Total Companies Profiled: 63 (including Divisions/Subsidiaries 72)
- The United States (22)
- Canada (1)
- Japan (5)
- Europe (14)
- - France (3)
- - Germany (2)
- - The United Kingdom (2)
- - Spain (1)
- - Rest of Europe (6)
- Asia-Pacific (Excluding Japan) (28)
- Latin America (1)
- Middle East (1)
For more information about this report visit http://www.researchandmarkets.com/research/8dt787/prophylactic
Related Topics: Vaccines